You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

chronic phase

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Renal Failure Trial in Nîmes, Avignon (chronic phase, acute phase)

Recruiting
  • Chronic Renal Failure
  • chronic phase
  • acute phase
  • Nîmes, Gard, France
  • +1 more
May 24, 2022

Stroke Trial in Ubbergen (Gait adaptability training)

Recruiting
  • Stroke
  • Gait adaptability training
  • Ubbergen, Netherlands
    Sint Maartenskliniek
Apr 11, 2023

Generic Imatinib Compared to Glivec® in Real-Life Management of

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Cairo, Egypt
  • +1 more
Mar 16, 2022

Chronic Leukemia Trial in France (Additional biological samples)

Active, not recruiting
  • Chronic Leukemia
  • Additional biological samples
  • Besançon, France
  • +3 more
May 31, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +11 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

Not yet recruiting
  • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
  • (no location specified)
Jun 7, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +13 more
  • CMVpp65-A*0201 peptide vaccine
  • +2 more
  • Duarte, California
  • +4 more
Jan 4, 2023

Chronic Myeloid Leukemia, Chronic Phase Trial in Beijing (Radotinib, Imatinib)

Active, not recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Beijing, China
    Peking University People's Hospital(北京大学人民医院)
Jan 3, 2022

Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Amman, Jordan
  • +4 more
Jan 17, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

Recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Birmingham, Alabama
  • +25 more
Jan 10, 2023

Stroke, Spinal Cord Injuries, Chronic Disease Trial in Herentals, Leuven (Intensive rehabilitation programme)

Recruiting
  • Stroke
  • +2 more
  • Intensive rehabilitation programme
  • Herentals, Belgium
  • +1 more
Jul 24, 2023

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

Chronic Myeloid Leukemia, Chronic Phase, Nilotinib Trial in Shenzhen (Nilotinib)

Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
  • Nilotinib
  • Shenzhen, Guangdong, China
    Shenzhen Second People's Hospital
Mar 15, 2022

Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

Terminated
Has Results
  • Chronic Phase Chronic Myeloid Leukemia
  • Ponatinib 30 mg QD
  • +2 more
  • Bruxelles, Belgium
    Cliniques Universitaire Saint-Luc (Site 058)
Oct 28, 2021

Stroke Trial in Leuven (Adapted H-GRASP feedback program)

Recruiting
  • Stroke
  • Adapted H-GRASP feedback program
  • Leuven, Belgium
    Private physiotherapy practices
May 17, 2022

"Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

Not yet recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Sohag, Egypt
      Sohag University Hospital
    Sep 14, 2022

    Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

    Recruiting
    • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Chronic Phase Chronic Myelogenous Leukemia
    • Text Message-Based Navigation Intervention
    • Survey Administration
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Apr 7, 2022

    Chronic Stroke Trial in Leuven (DeXtreme training (error-enhancement))

    Recruiting
    • Chronic Stroke
    • DeXtreme training (error-enhancement)
    • Leuven, Vlaams-Brabant, Belgium
      UZ Leuven
    Jul 26, 2022

    Traumatic Brain Injury Trial in Oslo (Patient-centered in home rehabilitation, Control)

    Completed
    • Traumatic Brain Injury
    • Patient-centered in home rehabilitation
    • Control
    • Oslo, Norway
      OUH
    Mar 11, 2022

    Among CP-CML Participants Initiating Dasatinib inReal Life

    Completed
    • Chronic Myeloid Leukemia
    • Non-Interventional
    • Paris, France
      Local Institution
    Jun 17, 2022

    Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)

    Active, not recruiting
    • Leukemia, Myeloid, Chronic-Phase
    • Halle (Saale), Saxony-Anhalt, Germany
    • +9 more
    Sep 9, 2022

    Chronic Hepatitis C Virus, Hepatitis C, Chronic, Hepatitis C Trial in Bucuresti (Bemnifosbuvir, Ruzasvir)

    Recruiting
    • Chronic Hepatitis C Virus
    • +4 more
    • Bucuresti, BUC, Romania
      Atea Study Site
    Jun 15, 2023

    Leukemia, Chronic Myelogenous Trial in Japan (Bosutinib)

    Completed
    Has Results
    • Leukemia, Chronic Myelogenous
    • Toyoake-City, Aichi, Japan
    • +20 more
    Apr 26, 2022

    Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

    Not yet recruiting
    • Chronic Myelogenous Leukemia
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Oct 12, 2023

    Chronic Hepatitis D Infection Trial in Changchun (Hepalatide, Hepalatide Placebo)

    Not yet recruiting
    • Chronic Hepatitis D Infection
    • Changchun, China
      The first hospital of Jilin University
    Apr 22, 2023